Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events

Rishi Puri1, Kathy Wolski, Kiyoko Uno

  • 1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

Insights

Risk factor modification therapies led to plaque regression in the left main coronary artery (LMCA), but progression occurred in epicardial segments. Patients experiencing major adverse cardiovascular events (MACE) showed progressive LMCA disease.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Atherosclerosis Research

Background:

  • Limited understanding of left main coronary artery (LMCA) atherosclerosis natural history and clinical impact.
  • Epicardial coronary disease progression slows with risk factor modification, but LMCA behavior is less understood.

Purpose of the Study:

  • To evaluate left main coronary artery (LMCA) atherosclerosis progression in patients undergoing risk factor modifying therapies.
  • To investigate the relationship between LMCA plaque burden changes, arterial remodeling, and major adverse cardiovascular events (MACE).

Main Methods:

  • Serial intravascular ultrasound imaging in 340 patients across 7 clinical trials.
  • Characterization of LMCA and epicardial coronary disease progression.
  • Analysis of plaque burden changes, remodeling, and MACE incidence.

Main Results:

  • Left main coronary artery (LMCA) plaque regression observed (-0.39% PAV), contrasting with epicardial segment progression (+0.37% PAV).
  • LMCA lumen volume changes correlated with external elastic membrane and plaque volume.
  • Patients with MACE had smaller baseline LMCA lumen area and greater plaque progression.

Conclusions:

  • Left main coronary artery (LMCA) atherosclerosis demonstrates responsiveness to systemic risk factor modification.
  • Progressive LMCA disease and constrictive remodeling are associated with increased MACE risk.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...